US · SRTS
Sensus Healthcare, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Boca Raton, FL 33487
- Website
- sensushealthcare.com
Price · as of 2025-12-31
$3.98
Market cap 67.51M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $113.88 | +2,761.31% |
| Intrinsic Value(DCF) | $2.56 | -35.68% |
| Graham-Dodd Method(GD) | $0.58 | -85.38% |
| Graham Formula(GF) | $11.62 | +192.01% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | $0.44 | $0.00 | |||
| 2016 | $4.69 | $49.90 | $165.08 | $0.00 | $0.00 |
| 2017 | $5.83 | $42.25 | $326.39 | $0.00 | $0.00 |
| 2018 | $7.61 | $47.84 | $110.62 | $1.16 | $0.00 |
| 2019 | $3.34 | $76.59 | $5.04 | $1.20 | $0.00 |
| 2020 | $4.32 | $76.44 | $0.46 | $0.00 | $22.40 |
| 2021 | $10.05 | $73.42 | $1,484.39 | $2.83 | $45.65 |
| 2022 | $5.29 | $65.49 | $3,798.51 | $10.27 | $102.86 |
| 2023 | $4.16 | $29.86 | $71.42 | $3.15 | $0.00 |
| 2024 | $4.60 | $108.58 | $164.93 | $5.46 | $31.14 |
| 2025 | $4.59 | $113.88 | $1.13 | $0.58 | $11.62 |
AI valuation
Our deep-learning model estimates Sensus Healthcare, Inc.'s (SRTS) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $113.88
- Current price
- $3.98
- AI upside
- +2,761.31%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2.56
-35.68% upside
Graham-Dodd
$0.58
-85.38% upside
Graham Formula
$11.62
+192.01% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SRTS | Sensus Healthcare, Inc. | $3.98 | 67.51M | +2,761% | -36% | -85% | +192% | -9.71 | 1.56 | 2.73 | -5.40 | — | 1.56 | 43.18% | -37.50% | -28.09% | -14.85% | -27.07% | -13.40% | 0.01 | — | 9.72 | 5.96 | 2.16 | -21463.00% | -3426.00% | -10000.00% | 0.00% | 0.00 | 0.00% | 0.00% | 0.00% | 0.00% | -5.19 | — | 1.95 | 10.06 |
| BDMD | Baird Medical Investment … | $2.98 | 109.44M | +1,873% | +2% | +34% | +311% | 8.01 | 2.55 | 2.73 | 7.35 | 41.06 | 2.55 | 88.16% | 41.35% | 33.62% | 33.41% | 26.96% | 18.71% | 0.53 | 26.55 | 1.77 | 1.43 | 1.11 | 1951.00% | 1774.00% | 15056.00% | -9.08% | -0.18 | -18.05% | 0.00% | 0.00% | 0.00% | 7.76 | -12.97 | 3.21 | 3.60 |
| CTSO | Cytosorbents Corporation | $0.75 | 47.26M | +3,558% | -47% | — | — | -2.65 | 4.95 | 1.54 | -5.17 | — | 7.47 | 70.59% | -47.16% | -58.21% | -120.52% | -49.92% | -41.18% | 2.42 | -12.00 | 2.20 | 1.08 | -1.55 | -4154.00% | 1451.00% | -3488.00% | -26.76% | -1.47 | -47.32% | 0.00% | 0.00% | 0.00% | -4.68 | -5.34 | 2.21 | -8.19 |
| ICCM | IceCure Medical Ltd | $0.58 | 39.85M | +4,441% | -7% | — | — | -4.48 | 9.95 | 20.87 | -4.01 | — | 9.95 | 44.09% | -476.94% | -465.45% | -160.70% | -2098.40% | -105.69% | 0.07 | — | 1.95 | 1.41 | 0.46 | -625.00% | 192.00% | -282.00% | -18.39% | -2.28 | -1689.04% | 0.00% | 0.00% | 0.00% | -3.92 | -4.87 | 18.71 | -7.83 |
| IPSC | Century Therapeutics, Inc… | $2.32 | 202.78M | +1,581% | -88% | — | — | -0.41 | 0.32 | 7.82 | 0.75 | — | 0.41 | 100.00% | -2096.48% | -1920.87% | -73.14% | -320.94% | -35.46% | 0.33 | — | 1.50 | 1.47 | 0.04 | -3000.00% | 19481.00% | 804.00% | -214.09% | -0.85 | -256.24% | 0.00% | 0.00% | 10.59% | 0.61 | 0.76 | -12.74 | -3.99 |
| KPTI | Karyopharm Therapeutics I… | $9.41 | 80.34M | +75% | -59% | — | — | -0.53 | -0.36 | 0.72 | -3.04 | -0.59 | -0.36 | 95.93% | -62.10% | -134.21% | 81.86% | 81.25% | -143.71% | -0.80 | -1.98 | 1.12 | 0.98 | -1.91 | 9054.00% | 57.00% | -4095.00% | -71.87% | -0.82 | 67.51% | 0.00% | 0.00% | 0.00% | -3.03 | -3.65 | 1.88 | -23.86 |
| MDAI | Spectral AI, Inc. | $1.40 | 42.96M | +2,693% | -59% | — | — | -1.69 | -3.56 | 0.87 | -2.21 | — | -3.56 | 44.87% | -22.25% | -51.77% | 341.85% | 101.83% | -134.42% | -0.65 | -2.22 | 0.57 | 0.43 | 0.04 | -4257.00% | 6383.00% | -3052.00% | -35.62% | -0.52 | 142.31% | 0.00% | 0.00% | 0.00% | -3.85 | -2.76 | 0.86 | -4.86 |
| MDCX | Medicus Pharma Ltd. Commo… | $1.53 | 37.8M | — | — | — | — | -2.63 | 9.36 | — | -2.29 | — | 9.36 | 0.00% | — | — | -525.44% | 1700.21% | -295.90% | 0.10 | -35.21 | 2.33 | 1.81 | 0.34 | -2810.00% | — | 14643.00% | -34.93% | -4.44 | 1558.23% | 0.00% | 0.00% | 7.24% | -2.28 | -2.49 | — | -6.04 |
| PETS | PetMed Express, Inc. | $2.74 | 58.64M | +949% | -13% | -57% | -8% | -13.01 | 0.96 | 0.36 | 4.15 | — | 1.81 | 30.46% | -0.67% | -2.76% | -6.90% | -4.12% | -3.94% | 0.01 | — | 1.26 | 0.91 | -8.01 | -1892.00% | -1719.00% | 10361.00% | -0.48% | 0.08 | -1.06% | 0.22% | -2.90% | 0.22% | -18.19 | -70.47 | 0.12 | 3.02 |
| SNTI | Senti Biosciences, Inc. | $0.94 | 24.82M | +2,578% | — | — | — | -0.31 | 0.63 | — | -0.03 | — | 0.63 | 0.00% | — | — | -114.06% | -153.24% | -48.58% | 1.31 | — | 4.49 | 3.81 | 0.27 | -4513.00% | -10000.00% | -3571.00% | -256.05% | -3.15 | -103.99% | 0.00% | 0.00% | 101.22% | -0.03 | -0.04 | — | -5.61 |
| TELA | TELA Bio, Inc. | $0.87 | 38.66M | +2,769% | +12% | — | — | -1.82 | 2.43 | 1.00 | -1.88 | — | 2.58 | 67.08% | -49.23% | -54.60% | -159.87% | -201.31% | -45.76% | 1.51 | -6.45 | 5.01 | 4.02 | 0.30 | -3480.00% | 1856.00% | 269.00% | -61.69% | -2.67 | -252.24% | 0.00% | 0.00% | 8.18% | -1.74 | -1.40 | 0.86 | -4.68 |
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
- CEO
- Joseph C. Sardano
- Employees
- 54
- Beta
- 1.19
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.56 ÷ $3.98) − 1 = -35.68% (DCF, example).